CareLit · DOI-Nachweis · Pneumologie
Influence of maintenance therapy on incidence of 2nd line therapy and OS in NSCLC IV
DOI 10.1055/s-0035-1544654
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Griesinger, A Lüers, R Prenzel, D Scriba, M Hoheisel, K Wedeken, KC Willborn
ZeitschriftPneumologie
Ausgabe02/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: One of the strongest rationale for maintenance therapy in NSCLC is the fact that exposure to 2nd line therapy is only 40 – 60% in clinical trials in specialized treatment centers. Even with follow-up intervals of 6 weeks, the 2nd line treatment rate does not seem to increase. We analyzed the exposure of 2nd line therapy as well as OS and PFS in patients with stage IV NSCLC in the subgroups no 2nd line,…
Zitieren
Zitierempfehlung
F Griesinger, A Lüers, R Prenzel, D Scriba, M Hoheisel, K Wedeken, KC Willborn (2015) Influence of maintenance therapy on incidence of 2nd line therapy and OS in NSCLC IV. Pneumologie (02). https://doi.org/10.1055/s-0035-1544654
Mit CareLit weiterarbeiten